6 research outputs found

    Studies of Copaifera luetzelburgii Harms in reproductive pharmacology: In vivo and in vitro approaches

    Get PDF
    The objective of this study was to evaluate the estrogenic and anti-estrogenic actions, as well as the reproductive and foetal toxicity, of the ethanol extract from Copaifera luetzelburgii (EEtOH-Cl). In the experiment of (anti) estrogenicity, nulliparous Wistar rats were treated for 3 days with EEtOH-Cl (125, 250 and 500 mg/kg); estradiol (E, 5 μg/kg); E + EEtOH-Cl; tamoxifen (T, 4mg/kg). This extract presented estrogenic activity by increasing the relative weight (%) of the uterus of rats treated at doses of 125, 250 and 500 mg/kg (0.267 ± 0.016*, 0.231 ± 0.014*, 0.242 ± 0.015*), and it showed anti-estrogenic activity when associated with estradiol (0.116 ± 0.006*, 0.103 ± 0.06*, 0.098 ± 0.05*), respectively. For assessment of toxicity in pregnancy, the animals were divided into two groups and treated daily with EEtOH-Cl. In the first group, the effect of the extract on the development of pregnancy from first to seventh day was observed, and in the second group, from 8 to 21 days, there was no change of these parameters or the viability of the progeny when the study assessed reproductive and foetal toxicity; however, there was shortening of pregnancy (125 mg/kg) without affecting the progeny. In the in vitro study, uterine strips of pregnant (P) and non-pregnant (NP) females were used. In both groups, half received EEtOH-Cl (vo) for 13 days (treated females - T), and the other half received EEtOH-Cl directly to the isolated organ bath system (untreated - NT). In vitro study on the uterus of pregnant animals pretreated with doses of 250 and 500 mg/kg showed that there was inhibition of KCl 80-induced phasic contractions (0.490 ± 0.110, 0.540 ± 0.092), respectively. Also, the contractions induced by oxytocin were inhibited at a dose of 500 mg/kg (0.380 ± 0.109). In non-pregnant, non-treated females, the extract at a concentration of 125 μg/mL (0.180 ± 0.062) also inhibited the contractions induced by oxytocin. Thus, EEtOH-Cl demonstrated estrogenic activity, but when combined with estradiol, it demonstrated anti-estrogenic activity. It did not induce toxicity in the progenitors or in the progeny, and it inhibited isometric contractions induced by oxytocin and KCl 80 mM in pregnant and non-pregnant rats.Keywords: Copaifera luetzelburgii, (anti-)estrogenicity, reproductive toxicity, phasic contractionsAfrican Journal of Biotechnology Vol. 12(24), pp. 3864-387

    Typification and quality control of the Andiroba (Carapa guianensis) oil via mass spectrometry fingerprinting

    No full text
    Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)The oil from the seeds of the 'Andiroba' tree, which is found throughout most tropical America, contains high levels of unsaturated triacylglycerols (TAG), which makes it attractive to the cosmetics industry. A significant amount of limonoids also confers to this Amazonian oil several pharmaceutical and medical properties. In addition, the oil is also a potential feedstock for biodiesel production, and its many uses have intensified its extractive exploitation in recent years. Herein we report on the characterization of the TAG, free fatty acids (FFA) and limonoid profiles of the Andiroba oil via mass spectrometry (MS) fingerprinting using direct electrospray ionization mass spectrometry (ESI-MS). An ambient desorption/ionization technique known as easy ambient sonic-spray ionization (EASI-MS) was also evaluated with similar results. ESI-MS was performed either for a methanolic solution of a few microliters of the fresh oil or from a simple aqueous extract whereas EASI-MS was applied directly to a droplet of the oil resting on a paper surface. The efficacy of these MS fingerprinting techniques requiring no pre-separation and no or very simple sample preparation protocols was investigated and compared for the typification and quality of this valuable Amazonian oil.5613851391Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Financing Agency of Studies and Projects (FINEP)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

    Hepatotoxicity of Immunomodulating Agents

    No full text
    corecore